{"id":"https://openalex.org/W3045303091","doi":"https://doi.org/10.1016/s2055-6640(20)31331-5","title":"Targeting HIV reservoir by DART molecules that recruit T cells to HIV Env expressing cells: comparison of HIV arms derived from broadly reactive neutralizing or non-neutralizing anti-Env antibodies","display_name":"Targeting HIV reservoir by DART molecules that recruit T cells to HIV Env expressing cells: comparison of HIV arms derived from broadly reactive neutralizing or non-neutralizing anti-Env antibodies","alternate_titles":[],"publication_year":2015,"publication_date":"2015-12-01","ids":{"openalex":"https://openalex.org/W3045303091","doi":"https://doi.org/10.1016/s2055-6640(20)31331-5","mag":"3045303091"},"language":"en","primary_location":{"id":"doi:10.1016/s2055-6640(20)31331-5","doi":"https://doi.org/10.1016/s2055-6640(20)31331-5","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s2055-6640(20)31331-5","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2055664020313315/pdf","source":{"id":"https://openalex.org/S2764990692","display_name":"Journal of Virus Eradication","issn_l":"2055-6640","issn":["2055-6640","2055-6659"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Virus Eradication","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3045303091"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S2055664020313315/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108566230","display_name":"Jeff Nordstrom","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.L. Nordstrom","raw_affiliation_strings":["MacroGenics, 9640 Medical Center Drive, Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, 9640 Medical Center Drive, Rockville, MD, USA","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031825313","display_name":"Derek D. Sloan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D.D. Sloan","raw_affiliation_strings":["Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074110558","display_name":"C.h.-Y. Kao Lam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C.Y. Kao Lam","raw_affiliation_strings":["MacroGenics, 9640 Medical Center Drive, Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, 9640 Medical Center Drive, Rockville, MD, USA","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070611278","display_name":"Alivelu Irrinki","orcid":"https://orcid.org/0000-0001-7922-1807","observed_orcids":["https://orcid.org/0000-0001-7922-1807"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Irrinki","raw_affiliation_strings":["Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011550307","display_name":"L. Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Liu","raw_affiliation_strings":["MacroGenics, 9640 Medical Center Drive, Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, 9640 Medical Center Drive, Rockville, MD, USA","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011932678","display_name":"Angela Tsai","orcid":"https://orcid.org/0000-0002-7836-6788","observed_orcids":["https://orcid.org/0000-0002-7836-6788"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Tsai","raw_affiliation_strings":["Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027013679","display_name":"Craig S. Pace","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C.S. Pace","raw_affiliation_strings":["Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Kaur","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Kaur","raw_affiliation_strings":["Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063112350","display_name":"Jeffrey P. Murry","orcid":"https://orcid.org/0000-0002-3716-1460","observed_orcids":["https://orcid.org/0000-0002-3716-1460"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.P. Murry","raw_affiliation_strings":["Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108414155","display_name":"Mini Balakrishnan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Balakrishnan","raw_affiliation_strings":["Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023294934","display_name":"Paul A. Moore","orcid":"https://orcid.org/0000-0001-6057-7539","observed_orcids":["https://orcid.org/0000-0001-6057-7539"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P.A. Moore","raw_affiliation_strings":["MacroGenics, 9640 Medical Center Drive, Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, 9640 Medical Center Drive, Rockville, MD, USA","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031117799","display_name":"Syd Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Johnson","raw_affiliation_strings":["MacroGenics, 9640 Medical Center Drive, Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, 9640 Medical Center Drive, Rockville, MD, USA","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030953900","display_name":"T. Cihlar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Cihlar","raw_affiliation_strings":["Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077925652","display_name":"Scott Koenig","orcid":"https://orcid.org/0000-0001-8181-4230","observed_orcids":["https://orcid.org/0000-0001-8181-4230"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Koenig","raw_affiliation_strings":["MacroGenics, 9640 Medical Center Drive, Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, 9640 Medical Center Drive, Rockville, MD, USA","institution_ids":["https://openalex.org/I4210106297"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":0.1201,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.38346667,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":94},"biblio":{"volume":"1","issue":null,"first_page":"14","last_page":"14"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-reservoir","display_name":"HIV reservoir","score":0.9440000057220459},{"id":"https://openalex.org/keywords/broadly-neutralizing-antibodies","display_name":"broadly neutralizing antibodies","score":0.8799999952316284},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.7960000038146973},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.8550000190734863},{"id":"https://openalex.org/keywords/pgt121","display_name":"PGT121","score":0.8270000219345093},{"id":"https://openalex.org/keywords/vrc01","display_name":"VRC01","score":0.7940000295639038},{"id":"https://openalex.org/keywords/7b2","display_name":"7B2","score":0.9100000262260437}],"concepts":[{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.7780579924583435},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.717627227306366},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6456535458564758},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.5230886936187744},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36182355880737305},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24695467948913574},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.2466857135295868}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/s2055-6640(20)31331-5","doi":"https://doi.org/10.1016/s2055-6640(20)31331-5","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s2055-6640(20)31331-5","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2055664020313315/pdf","source":{"id":"https://openalex.org/S2764990692","display_name":"Journal of Virus Eradication","issn_l":"2055-6640","issn":["2055-6640","2055-6659"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Virus Eradication","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:7c5ce97faf9b4ef3b04dca28dc8b560e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/7c5ce97faf9b4ef3b04dca28dc8b560e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Virus Eradication, Vol 1, Iss , Pp 14- (2015)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/s2055-6640(20)31331-5","doi":"https://doi.org/10.1016/s2055-6640(20)31331-5","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s2055-6640(20)31331-5","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2055664020313315/pdf","source":{"id":"https://openalex.org/S2764990692","display_name":"Journal of Virus Eradication","issn_l":"2055-6640","issn":["2055-6640","2055-6659"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Virus Eradication","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.979200005531311}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3045303091.pdf","grobid_xml":"https://content.openalex.org/works/W3045303091.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3044850646","https://openalex.org/W3044357146","https://openalex.org/W2157737444","https://openalex.org/W2150457116","https://openalex.org/W3196815440","https://openalex.org/W2288310278","https://openalex.org/W3042195814","https://openalex.org/W4293379267","https://openalex.org/W3041329488"],"abstract_inverted_index":{"Background:":[0],"HIV":[1,64,143,182,213,266],"reservoirs":[2,240],"and":[3,20,48,103,117,187,210,226,237],"production":[4],"of":[5,33,45,98,134,175,231,255],"viral":[6,38,239],"antigens":[7],"are":[8,24],"not":[9,123,197],"eliminated":[10],"in":[11,62,157,185,202,241],"HIV-infected":[12,46,99,169,232],"individuals":[13,170,245],"treated":[14],"with":[15,74,141,151,212],"combination":[16],"antiretroviral":[17],"therapy":[18],"(cART)":[19],"novel":[21],"therapeutic":[22,262],"strategies":[23],"needed.Dual-Affinity":[25],"Re-Targeting":[26],"(DART)":[27],"molecules":[28,153,180,195,224,258],"exhibit":[29],"a":[30,260],"distinct":[31],"mechanism":[32],"action":[34],"via":[35],"binding":[36,86,92],"the":[37,43,176,229],"envelope":[39],"(Env)":[40],"antigen":[41,85,91],"on":[42,52,105,171,246],"surface":[44,90],"cells":[47,139,166,242],"simultaneously":[49],"engaging":[50],"CD3":[51],"cytotoxic":[53],"T":[54,138,207],"lymphocytes":[55],"(CTLs).Methods:":[56],"HIVxCD3":[57,108,222,256],"DART":[58,109,152,179,194,223,257],"proteins":[59,110],"were":[60,66,82],"made":[61],"which":[63],"arms":[65,214],"derived":[67,111,215],"from":[68,112,124,168,216,244],"diverse":[69,142],"broadly":[70],"reactive":[71],"Env-specific":[72],"antibodies":[73],"(bnAbs)":[75],"or":[76,204],"without":[77],"(non-nAbs)":[78],"virus":[79,106,200,219],"neutralizing":[80,220],"activity.They":[81],"evaluated":[83],"for":[84,156,252,264],"by":[87,93],"ELISA,":[88],"cell":[89,192,208],"flow":[94],"cytometry,":[95],"CD8-dependent":[96],"killing":[97,133,230],"Env-expressing":[100],"target":[101],"cells,":[102],"effect":[104],"propagation.Results:":[107],"two":[113,118,125],"bnAbs":[114,127,217],"(PGT121,":[115],"PGT145)":[116],"non-nAbs":[119],"(A32,":[120],"7B2),":[121],"but":[122],"other":[126],"(VRC01,":[128],"10E8),":[129],"mediated":[130],"potent":[131,178],"CTL-dependent":[132],"quiescent":[135,186],"primary":[136],"CD4":[137,206],"infected":[140],"isolates.Similar":[144],"redirected":[145],"CTL":[146],"activity":[147],"was":[148],"also":[149],"observed":[150],"structurally":[154],"modified":[155],"vivo":[158,163],"half-life":[159],"extension.In":[160],"an":[161],"ex":[162],"model":[164],"using":[165],"isolated":[167,243],"suppressive":[172],"cART,":[173],"combinations":[174],"most":[177],"reduced":[181],"expression":[183],"both":[184],"activated":[188,205,238],"peripheral":[189],"blood":[190],"mononuclear":[191],"cultures.Importantly,":[193],"did":[196],"induce":[198],"cell-to-cell":[199],"spread":[201],"resting":[203,236],"cultures":[209],"ones":[211],"retained":[218],"activity.Conclusion:":[221],"potently":[225],"selectively":[227],"mediate":[228],"cells.Furthermore,":[233],"they":[234],"perturb":[235],"antiviral":[247],"therapy.The":[248],"data":[249],"provide":[250],"support":[251],"further":[253],"pursuit":[254],"as":[259],"promising":[261],"strategy":[263],"targeting":[265],"reservoirs.":[267]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3045303091","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2020-07-29T00:00:00"}
